149 related articles for article (PubMed ID: 37970236)
1. COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B.
Shin H; Lee HS; Noh JY; Koh JY; Kim SY; Park J; Chung SW; Hur MH; Park MK; Lee YB; Kim YJ; Yoon JH; Ko JH; Peck KR; Song JY; Shin EC; Lee JH
Immune Netw; 2023 Oct; 23(5):e39. PubMed ID: 37970236
[TBL] [Abstract][Full Text] [Related]
2. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
[TBL] [Abstract][Full Text] [Related]
3. Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy.
Cao W; Lu H; Zhang L; Wang S; Deng W; Jiang T; Lin Y; Yang L; Bi X; Lu Y; Zhang L; Shen G; Liu R; Chang M; Wu S; Gao Y; Hao H; Xu M; Chen X; Hu L; Xie Y; Li M
Front Immunol; 2022; 13():1067362. PubMed ID: 36479104
[TBL] [Abstract][Full Text] [Related]
4. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.
Li F; Wei H; Wei H; Gao Y; Xu L; Yin W; Sun R; Tian Z
Gastroenterology; 2013 Feb; 144(2):392-401. PubMed ID: 23103614
[TBL] [Abstract][Full Text] [Related]
5. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
[TBL] [Abstract][Full Text] [Related]
6. Increased ILT2 expression contributes to dysfunction of CD56
Zhang Y; Tong S; Li S; Wang X; Ren H; Yin W
Antiviral Res; 2022 Sep; 205():105385. PubMed ID: 35917968
[TBL] [Abstract][Full Text] [Related]
7. Functional restoration of CD56
Chen T; Zhu L; Shi A; Ding L; Zhang X; Tan Z; Guo W; Yan W; Han M; Jia J; Luo X; Schuppan D; Ning Q
Hepatol Int; 2017 Sep; 11(5):419-428. PubMed ID: 28639033
[TBL] [Abstract][Full Text] [Related]
8. Cases of Rapid Hepatitis B Surface Antigen Reduction after COVID-19 Vaccination.
Osawa Y; Ohtake T; Suto D; Akita T; Yamada H; Kohgo Y; Murata K
Intern Med; 2023 Jan; 62(1):51-57. PubMed ID: 36261382
[TBL] [Abstract][Full Text] [Related]
9. CD56
Shi A; Zhang X; Xiao F; Zhu L; Yan W; Han M; Luo X; Chen T; Ning Q
J Viral Hepat; 2018 Nov; 25(11):1352-1362. PubMed ID: 29888839
[TBL] [Abstract][Full Text] [Related]
10. Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study.
Gane E; Verdon DJ; Brooks AE; Gaggar A; Nguyen AH; Subramanian GM; Schwabe C; Dunbar PR
J Hepatol; 2019 Nov; 71(5):900-907. PubMed ID: 31306680
[TBL] [Abstract][Full Text] [Related]
11. Recovery of circulating CD56
Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
[TBL] [Abstract][Full Text] [Related]
12. The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection.
Du Y; Anastasiou OE; Strunz B; Scheuten J; Bremer B; Kraft A; Kleinsimglinhaus K; Todt D; Broering R; Hardtke-Wolenski M; Wu J; Yang D; Dittmer U; Lu M; Cornberg M; Björkström NK; Khera T; Wedemeyer H
Liver Int; 2021 Sep; 41(9):2046-2058. PubMed ID: 33794040
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B.
Lee HA; Seo YS; Park SW; Park SJ; Kim TH; Suh SJ; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH
Clin Mol Hepatol; 2016 Sep; 22(3):382-389. PubMed ID: 27729633
[TBL] [Abstract][Full Text] [Related]
14. Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study.
Wu D; Wang P; Han M; Chen Y; Chen X; Xia Q; Yan W; Wan X; Zhu C; Xie Q; Jiang J; Wei L; Tan D; Dou X; Yu Y; Hou J; Luo X; Ning Q
Hepatol Int; 2019 Sep; 13(5):573-586. PubMed ID: 31172415
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B e Antigen Induces NKG2A
Ma Q; Dong X; Liu S; Zhong T; Sun D; Zong L; Zhao C; Lu Q; Zhang M; Gao Y; Ye Y; Cheng J; Xu Y; Zheng M
Front Cell Dev Biol; 2020; 8():421. PubMed ID: 32582704
[TBL] [Abstract][Full Text] [Related]
16. Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study.
Lai MW; Hsu CW; Lin CL; Chien RN; Lin WR; Chang CS; Liang KH; Yeh CT
Hepatol Int; 2018 Sep; 12(5):456-464. PubMed ID: 30088198
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study.
Zeng LY; Lian JS; Chen JY; Jia HY; Zhang YM; Xiang DR; Yu L; Hu JH; Lu YF; Zheng L; Li LJ; Yang YD
World J Gastroenterol; 2014 Jul; 20(27):9178-84. PubMed ID: 25083092
[TBL] [Abstract][Full Text] [Related]
18. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
19. Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
Yoshioka T; Tatsumi T; Miyagi T; Mukai K; Nishio K; Nishio A; Yokoyama Y; Suda T; Kegasawa T; Shigekawa M; Hikita H; Sakamori R; Takehara T
PLoS One; 2017; 12(3):e0174103. PubMed ID: 28328926
[TBL] [Abstract][Full Text] [Related]
20. Pronounced decline of serum HBsAg in chronic hepatitis B patients with long-term effective nucleos(t)ide analogs therapy.
Wang ML; Chen EQ; Tao CM; Zhou TY; Liao J; Zhang DM; Wang J; Tang H
Scand J Gastroenterol; 2017 Dec; 52(12):1420-1426. PubMed ID: 28880694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
